Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...

A study from FAU has shown that lipid nanoparticles restructure their membrane significantly after being absorbed into a cell and ending up in an acidic environment. Vaccines and other medicines are ...

LIBERTY is part of the Company’s broader REVOLUTION clinical program designed to elaborate the profile of monoclonal antibody-mediated prophylaxis from COVID-19 and the potential medical benefits to ...

A new study shows lipid nanoparticles can be formulated at much higher lipid concentrations using a modular mixing approach, ...

Benitec Biopharma Inc. reports 100% responder rates for BB-301 with a mid-2026 FDA meeting ahead. See why BNTC stock is upgraded to buy.

While the fabled fountain of youth may not actually exist, a new type of therapy now does.

With a budget of up to $20m, the collaboration will establish scalable, rapid manufacturing for recombinant-protein vaccines.

Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...

Pick two.” But a team from the University of Virginia School of Medicine has discovered a way to make vaccines that embrace ...

Tom Gardner outlines two selective AI opportunities and a disciplined portfolio framework for the next three to five years.

The global vaccine Contract Development and Manufacturing Organization (CDMO) market is projected to expand at a compound ...